Djamila Hamada Saoud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Djamila Hamada Saoud has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Abdelatif Aouadi
Laboratory of Biotechnology Biomaterials and Condensed Matter (LBBCM), Faculty of Technology, University of El Oued, El Oued, Algeria
5 shared publications - Abderrhmane Bouafia
Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, El Oued, Algeria
5 shared publications - Salah Eddine Laouini
Department of Process Engineering and Petrochemistry, Faculty of Technology University of El Oued El Oued Algeria
5 shared publications - Mahmood M. S. Abdullah
Surfactant Research Chair, Chemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
3 shared publications - Abdelhak Achouri
Water, Environment and Sustainable Development Laboratory (2E2D), Faculty of Technology, University of Blida 1, Blida, Algeria
2 shared publications - Hamdi Ali Mohammed
Department of Process Engineering, Faculty of Technology, University of El Oued, El-Oued, Algeria
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities
A ZnO/CuO@amoxicillin nanocomposite was synthesized via a sol–gel route and characterized as a biphasic wurtzite ZnO–monoclinic CuO system with crystallite sizes of about 10–12 nm and an optical band gap of 3.30–3.36 eV, indicating defect‐rich interfaces favorable for redox activity. In antidiabetic assays, the nanocomposite showed strong inhibitory effects on alpha‐amylase (IC 50 = 21.57 ± 1.68 mg/mL) and alpha‐glucosidase (IC 50 = 13.95 ± 0.76 mg/mL), with activities comparable to acarbose, while anti‐inflammatory tests yielded low IC 50 values of 0.22 ± 0.03 mg/mL for egg albumin denaturation and 0.34 ± 0.07 mg/mL for human serum albumin, approaching the performance of diclofenac. Antioxidant performance was outstanding, with total antioxidant capacity of 298.27 ± 4.70 mg ascorbic acid equivalents per gram and ferric reducing antioxidant power of 311.67 ± 2.53 mM Fe 2 + /g, both higher than ascorbic acid, alongside efficient hydrogen peroxide scavenging (IC 50 = 0.16 ± 0.04 mg/mL) and protection against H 2 O 2 /FeCl 3 ‐induced hemolysis at an IC 50 of 0.007 ± 0.00 mg/mL; together with moderate but significant acetylcholinesterase inhibition (IC 50 = 33.16 ± 3.02 mg/mL vs. 21.80 ± 2.74 mg/mL for donepezil), these results support ZnO/CuO@amoxicillin as a multifunctional nano‐platform for managing oxidative stress, inflammation, and metabolic disorders.
- 3 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Open AccessSynthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities
A ZnO/CuO@amoxicillin nanocomposite was synthesized via a sol–gel route and characterized as a biphasic wurtzite ZnO–monoclinic CuO system with crystallite sizes of about 10–12 nm and an optical band gap of 3.30–3.36 eV, indicating defect‐rich interfaces favorable for redox activity. In antidiabetic assays, the nanocomposite showed strong inhibitory effects on alpha‐amylase (IC 50 = 21.57 ± 1.68 mg/mL) and alpha‐glucosidase (IC 50 = 13.95 ± 0.76 mg/mL), with activities comparable to acarbose, while anti‐inflammatory tests yielded low IC 50 values of 0.22 ± 0.03 mg/mL for egg albumin denaturation and 0.34 ± 0.07 mg/mL for human serum albumin, approaching the performance of diclofenac. Antioxidant performance was outstanding, with total antioxidant capacity of 298.27 ± 4.70 mg ascorbic acid equivalents per gram and ferric reducing antioxidant power of 311.67 ± 2.53 mM Fe 2 + /g, both higher than ascorbic acid, alongside efficient hydrogen peroxide scavenging (IC 50 = 0.16 ± 0.04 mg/mL) and protection against H 2 O 2 /FeCl 3 ‐induced hemolysis at an IC 50 of 0.007 ± 0.00 mg/mL; together with moderate but significant acetylcholinesterase inhibition (IC 50 = 33.16 ± 3.02 mg/mL vs. 21.80 ± 2.74 mg/mL for donepezil), these results support ZnO/CuO@amoxicillin as a multifunctional nano‐platform for managing oxidative stress, inflammation, and metabolic disorders.
- Open Access
Freezing Non-Equilibrium Structural Defects in Integrated Cu4MgO5/ZnO Nanocomposites for Extended Visible-Light-Driven Solar Fuel Production
The rational configuration of electronic band structures through deep-seated structural disorder remains a formidable challenge in sustainable solar-to-fuel conversion. Herein, we report a transformative kinetic strategy to “freeze” an extraordinary density of non-equilibrium structural defects within an integrated Cu4MgO5/ZnO nanocomposite. Synthesized via a chitosan-assisted coordination-combustion route followed by rapid thermal quenching, the material preserves a record crystallographic dislocation density of 1.09 × 1015 m−2 and significant lattice microstrain (1.04 × 10−3). This engineered structural disorder induces a profound reconfiguration of the electronic landscape, generating a continuous manifold of sub-bandgap “tail states” that narrow the optical bandgap to a remarkable 1.34 eV. Consequently, the defect-rich architecture facilitates unprecedented dual-channel photocatalytic performance under simulated solar irradiation in an aqueous solution containing 5 vol% triethanolamine (TEOA) as a sacrificial electron donor; the catalyst achieved a hydrogen evolution rate of 17,700.0 µmol g−1 h−1 and a methane production rate of 172.50 µmol g−1 h−1—representing a 36.3-fold and 43.1-fold enhancement over commercial ZnO, respectively. With an apparent quantum yield of 8.42% at 420 nm and robust photostability—maintaining 95.3% of its activity over five consecutive cycles (25 h total)—this noble-metal-free ternary system bypasses the limitations of traditional heterojunctions. Our findings establish a new benchmark for defect-engineered catalysts, providing a scalable blueprint for high-efficiency carbon neutrality and solar fuel production.
Open AccessFreezing Non-Equilibrium Structural Defects in Integrated Cu4MgO5/ZnO Nanocomposites for Extended Visible-Light-Driven Solar Fuel Production
The rational configuration of electronic band structures through deep-seated structural disorder remains a formidable challenge in sustainable solar-to-fuel conversion. Herein, we report a transformative kinetic strategy to “freeze” an extraordinary density of non-equilibrium structural defects within an integrated Cu4MgO5/ZnO nanocomposite. Synthesized via a chitosan-assisted coordination-combustion route followed by rapid thermal quenching, the material preserves a record crystallographic dislocation density of 1.09 × 1015 m−2 and significant lattice microstrain (1.04 × 10−3). This engineered structural disorder induces a profound reconfiguration of the electronic landscape, generating a continuous manifold of sub-bandgap “tail states” that narrow the optical bandgap to a remarkable 1.34 eV. Consequently, the defect-rich architecture facilitates unprecedented dual-channel photocatalytic performance under simulated solar irradiation in an aqueous solution containing 5 vol% triethanolamine (TEOA) as a sacrificial electron donor; the catalyst achieved a hydrogen evolution rate of 17,700.0 µmol g−1 h−1 and a methane production rate of 172.50 µmol g−1 h−1—representing a 36.3-fold and 43.1-fold enhancement over commercial ZnO, respectively. With an apparent quantum yield of 8.42% at 420 nm and robust photostability—maintaining 95.3% of its activity over five consecutive cycles (25 h total)—this noble-metal-free ternary system bypasses the limitations of traditional heterojunctions. Our findings establish a new benchmark for defect-engineered catalysts, providing a scalable blueprint for high-efficiency carbon neutrality and solar fuel production.
- 29 January 2026
- Published by Springer Nature in Ionics
- Vol. 32 (3) , 3103-3121
Defect-engineered MgO nanoparticles with high surface area for integrated solar-driven CO2 reduction and hydrogen generation
- 29 January 2026
- Published by Springer Nature in Ionics
- Vol. 32 (3) , 3103-3121
Defect-engineered MgO nanoparticles with high surface area for integrated solar-driven CO2 reduction and hydrogen generation
- 23 December 2023
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 15 (1) , 545-561
Synergistic chitin-zinc nanocomposites from shrimp shell waste: characterization, antioxidant, and antibacterial properties
- 23 December 2023
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 15 (1) , 545-561
Synergistic chitin-zinc nanocomposites from shrimp shell waste: characterization, antioxidant, and antibacterial properties
- 4 May 2023
- Published by Springer Nature in Chemistry Africa
- Vol. 6 (6) , 2817-2825
Fatty Acids Composition, Total Phenolics Content, Antioxidant and Antibacterial Activities of Algerian Ziziphus lotus L. (Desf.) Fruit Oil
- 4 May 2023
- Published by Springer Nature in Chemistry Africa
- Vol. 6 (6) , 2817-2825
Fatty Acids Composition, Total Phenolics Content, Antioxidant and Antibacterial Activities of Algerian Ziziphus lotus L. (Desf.) Fruit Oil
- 25 January 2023
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 14 (14) , 16257-16271
Phytochemical screening of aerial organs of wild fennel essential oils from southeast Algeria: identification of chemical composition, antioxidant, and antimicrobial activities
- 25 January 2023
- Published by Springer Nature in Biomass Conversion and Biorefinery
- Vol. 14 (14) , 16257-16271
Phytochemical screening of aerial organs of wild fennel essential oils from southeast Algeria: identification of chemical composition, antioxidant, and antimicrobial activities